3XC-83388-02988
3 vaccinations
3 coded responses
13 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 314 / GA
- Registered
- 2021-04-06
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-29
Dose 1 — Pfizer-BioNTech
-
2021-04-06
Registered in v-safe
- 2021-04-06
-
2021-04-19
Dose 2 — Pfizer-BioNTech
- 2021-04-19
-
2021-04-20
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
- 2021-04-21
- 2021-04-24
- 2021-05-12
- 2021-05-31
-
2021-12-02
Dose 3 — Pfizer-BioNTech
- 2021-12-02
-
2021-12-03
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-12-04
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain, Redness, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessFree text: Swollen lymph nodes in arm pit of injected armMedDRA releases: 2024-11 · check-in free text available
-
2021-12-06
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: Fair · Site: Redness, SwellingFree text: Swollen lymph nodes in arm pit of injection armMedDRA releases: 2024-11 · check-in free text available
- 2022-06-02
-
2022-12-04
Survey response — 12 months, dose 3MedDRA: Cough, Pyrexia — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: Fever, coughMedDRA releases: 2024-11 · check-in free text available
-
2022-12-04
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
-
2022-12-06
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-29 | Pfizer-BioNTech | |
| 2 | 2021-04-19 | Pfizer-BioNTech | |
| 3 | 2021-12-02 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-12-04 | Successful 2022-12-06 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Swollen lymph nodes in arm pit of injected arm
Systemic reaction (other): Swollen lymph nodes in arm pit of injection arm
Release 12 — 12 months, dose 3
Symptoms: Fever, cough
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SRO | Lymphadenopathy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release